Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 46338

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Tyroserleutide is an antitumor tripeptide.1,2,3 It inhibits the invasion of MHCC97-L hepatocellular carcinoma (HCC) cells at 100 µg/ml.2 Tyroserleutide induces the production of IL-1β, TNF-α, and nitric oxide (NO) in isolated mouse peritoneal macrophages and enhances the cytotoxic effect of isolated mouse peritoneal macrophages against BEL-7402 HCC and B16/F10 melanoma cells.3 It increases survival in an H22 murine hepatoma model at 10-80 µg/kg and decreases the rate of pulmonary metastasis in an MHCC97-L mouse xenograft model at 160 µg/kg.1,2 Tyroserleutide also decreases radiation-induced increases in intratumoral levels of transmembrane serine protease 4 (TMPRSS4) and hypoxia-inducible factor 1α (HIF-1α) in an MHCC97-L mouse xenograft model.2
WARNING This product is not for human or veterinary use.
1. Studies on the large scale synthesis and anti-
2. A novel tripeptide, tyroserleutide, inhibits irradiation-
3. Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-